Rory B Riggs - Net Worth and Insider Trading
Rory B Riggs Net Worth
The estimated net worth of Rory B Riggs is at least $25 Million dollars as of 2024-11-05. Rory B Riggs is the CEO, 10% Owner of Cibus Inc and owns about 2,727,883 shares of Cibus Inc (CBUS) stock worth over $11 Million. Rory B Riggs is the Director of Intra-Cellular Therapies Inc and owns about 116,600 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $10 Million. Rory B Riggs is also the Director of Royalty Pharma PLC and owns about 120,286 shares of Royalty Pharma PLC (RPRX) stock worth over $3 Million. Besides these, Rory B Riggs also holds FibroGen Inc (FGEN) . Details can be seen in Rory B Riggs's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rory B Riggs has not made any transactions after 2024-06-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rory B Riggs
Rory B Riggs Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rory B Riggs owns 4 companies in total, including Royalty Pharma PLC (RPRX) , Intra-Cellular Therapies Inc (ITCI) , and FibroGen Inc (FGEN) among others .
Click here to see the complete history of Rory B Riggs’s form 4 insider trades.
Insider Ownership Summary of Rory B Riggs
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RPRX | Royalty Pharma PLC | 2024-01-04 | director |
| ITCI | Intra-Cellular Therapies Inc | 2024-06-24 | director |
| FGEN | FibroGen Inc | 2018-03-13 | director |
 | | 2023-12-12 | director & Chief Executive Officer |
Rory B Riggs Latest Holdings Summary
Rory B Riggs currently owns a total of 4 stocks. Among these stocks, Rory B Riggs owns 2,727,883 shares of Cibus Inc (CBUS) as of December 12, 2023, with a value of $11 Million and a weighting of 45.64%. Rory B Riggs owns 116,600 shares of Intra-Cellular Therapies Inc (ITCI) as of June 24, 2024, with a value of $10 Million and a weighting of 40.09%. Rory B Riggs also owns 120,286 shares of Royalty Pharma PLC (RPRX) as of January 4, 2024, with a value of $3 Million and a weighting of 13.04%. The other 1 stocks FibroGen Inc (FGEN) have a combined weighting of 1.23% among all his current holdings.
Latest Holdings of Rory B Riggs
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CBUS | Cibus Inc | 2023-12-12 | 2,727,883 | 4.20 | 11,457,109 |
| ITCI | Intra-Cellular Therapies Inc | 2024-06-24 | 116,600 | 86.31 | 10,063,746 |
| RPRX | Royalty Pharma PLC | 2024-01-04 | 120,286 | 27.21 | 3,272,982 |
| FGEN | FibroGen Inc | 2018-03-13 | 984,913 | 0.31 | 307,687 |
Holding Weightings of Rory B Riggs
Rory B Riggs Form 4 Trading Tracker
According to the SEC Form 4 filings, Rory B Riggs has made a total of 1 transactions in Cibus Inc (CBUS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cibus Inc is the acquisition of 517,107 shares on December 12, 2023, which cost Rory B Riggs around $5 Million.
According to the SEC Form 4 filings, Rory B Riggs has made a total of 2 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Intra-Cellular Therapies Inc is the sale of 4,462 shares on June 24, 2024, which brought Rory B Riggs around $337,193.
According to the SEC Form 4 filings, Rory B Riggs has made a total of 18 transactions in Royalty Pharma PLC (RPRX) over the past 5 years, including 1 buys and 17 sells. The most-recent trade in Royalty Pharma PLC is the sale of 470,000 shares on January 4, 2024, which brought Rory B Riggs around $13 Million.
More details on Rory B Riggs's insider transactions can be found in the Insider Trading History of Rory B Riggs table.Insider Trading History of Rory B Riggs
- 1
Rory B Riggs Trading Performance
GuruFocus tracks the stock performance after each of Rory B Riggs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rory B Riggs is 21.49%. GuruFocus also compares Rory B Riggs's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rory B Riggs within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rory B Riggs's insider trading performs compared to the benchmark.
Performance of Rory B Riggs
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19 | | | | | |
| Relative Return to S&P 500(%) | 13.94 | | | | | |
Rory B Riggs Ownership Network
Ownership Network List of Rory B Riggs
Ownership Network Relation of Rory B Riggs
Rory B Riggs Owned Company Details
What does Royalty Pharma PLC do?
Who are the key executives at Royalty Pharma PLC?
Rory B Riggs is the director of Royalty Pharma PLC. Other key executives at Royalty Pharma PLC include 10 percent owner Avara Management Ltd , EVP & CFO Terrance P. Coyne , and director & CEO & Chairman of the Board Pablo G. Legorreta .
Royalty Pharma PLC (RPRX) Insider Trades Summary
Over the past 18 months, Rory B Riggs made 2 insider transaction in Royalty Pharma PLC (RPRX) with a net sale of 2,220,000. Other recent insider transactions involving Royalty Pharma PLC (RPRX) include a net purchase of 600,000 shares made by Pablo G. Legorreta , a net sale of 934,197 shares made by Avara Management Ltd , and a net sale of 150,000 shares made by Terrance P. Coyne .
In summary, during the past 3 months, insiders sold 0 shares of Royalty Pharma PLC (RPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,496,418 shares of Royalty Pharma PLC (RPRX) were sold and 600,000 shares were bought by its insiders, resulting in a net sale of 2,896,418 shares.
Royalty Pharma PLC (RPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Royalty Pharma PLC Insider Transactions
Rory B Riggs Mailing Address
Above is the net worth, insider trading, and ownership report for Rory B Riggs. You might contact Rory B Riggs via mailing address: 65 Railroad Ave, Ridgefield Nj 07657.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
